Stockscreener 앱 받기
2.375
1.12%
0.025
전일 마감가:
$2.35
열려 있는:
$2.35
하루 거래량:
610.79K
Relative Volume:
0.21
시가총액:
$337.58M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-2.6374
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
+4.91%
1개월 성능:
-26.20%
6개월 성능:
-71.78%
1년 성능:
-72.59%
1일 변동 폭
$2.35
$2.415
1주일 범위
$2.19
$2.47
52주 변동 폭
$2.07
$11.55
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.375 | 337.58M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.02 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.60 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.95 | 36.26B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.83 | 34.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
268.08 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action PendingHagens Berman - TradingView
ROSEN, A RANKED AND LEADING FIRM, Encourages Maravai - GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to - Bluefield Daily Telegraph
DEADLINE ALERT for SWKS, MRVI, APP, and RC: The Law Offices - GlobeNewswire
Are Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Analysts Predicting A Spike? - Stocks Register
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights -MRVI - ACCESS Newswire
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Faruqi & Faruqi Reminds Maravai Investors of the Pending - GlobeNewswire
MRVI Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit - PR Newswire
Shareholders that lost money on Maravai LifeSciences Holdings, Inc. (MRVI) should contact The - Bluefield Daily Telegraph
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Maravai LifeSciences Holdings, Inc. to Contact the Firm Today! - Markets Insider
Charles Schwab Investment Management Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Price Target Lowered to $5.00 at Morgan Stanley - Defense World
Urgent Action Required for Maravai LifeSciences Investors Before May 5 Deadline - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. Class Action: Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skyworks Solutions, Maravai, AppLovin, and Manhattan Associates and Encourages Investors to Contact the Firm - TradingView
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit - Marketscreener.com
Maravai Investors Face Crucial Deadline: Class Action Claims Hidden Financial Issues - StockTitan
Breaking Down Maravai LifeSciences: 4 Analysts Share Their Views - Benzinga
Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management? - Insider Monkey
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. - PR Newswire
Investors who lost money with shares of Maravai LifeSciences - openPR
Maravai LifeSciences Holdings, Inc. Sued for Securities Law - GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to - Bluefield Daily Telegraph
ROSEN, A TOP RANKED LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI - TradingView
Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities - GlobeNewswire
Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - Business Wire
Maravai Faces Major Lawsuit After 21% Stock Crash: Deadline Approaches - StockTitan
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Cl - GuruFocus.com
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
MRVI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Class Action Reminder for MRVI Investors: Kessler Topaz - GlobeNewswire
Class Action Reminder for MRVI Investors: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Securities Fraud Class Action Lawsuit - GlobeNewswire Inc.
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire
Bank of New York Mellon Corp Sells 83,940 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Farther Finance Advisors LLC Has $56,000 Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down After Analyst Downgrade - Armenian Reporter
UBS Group Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - Defense World
Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact Levi & Korsinsky about pending Class ActionMRVI - ACCESS Newswire
Maravai Lifesciences price target lowered to $5 from $10 at Stifel - Yahoo Finance
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - PR Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2024 Earnings Call Transcript - Insider Monkey
Victory Capital Management Inc. Grows Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Earnings Call: Growth Amid Challenges - TipRanks
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.02%
자본화:
|
볼륨(24시간):